Acknowledgement
Supported by : Korean Research Foundation
References
- Adams, G.R., and Haddad, F. (1996). The relationships among IGF-I, DNA content, and protein accumulation during skeletal muscle hypertrophy. J. Appl. Physiol. 81, 2509-2516 https://doi.org/10.1152/jappl.1996.81.6.2509
- Antonio, J., Wilson, J.D., and George, F.W. (1996). Effects of castration and androgen treatment on androgen receptor levels in rat skeletal muscle. J. Appl. Physiol. 87, 2016-2019
- Brunn, G.J., Hudson, C.C., Sekulic A., Williams, J.M., Hosoi, H., Houghton, P.J., Lawrence, J.C. Jr, and Abraham, R.T. (1997). Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277, 99-101 https://doi.org/10.1126/science.277.5322.99
- Chen, Y., Zajac, J.D., and MacLean, H.E. (2005). Androgen regulation of satellite cell function. J. Endocrinol. 186, 21-31 https://doi.org/10.1677/joe.1.05976
- Culig, Z., Hobisch, A., Cronauer, M.V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., and Klocker, H. (1994). Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 54, 5474-5478
- Fanzani, A., Colombo, F., Giuliani, R., Preti, A., and Marchesini, S. (2006). Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy. FEBS J. 273, 3709-3721
- Frost, R.A., and Lang, C.H. (1999). Differential effects of insulin-like growth factor I (IGF-I) and IGF-binding protein-1 on protein metabolism in human skeletal muscle cells. Endocrinology 140, 3962-3970 https://doi.org/10.1210/en.140.9.3962
- Galvin, C.D., Hardiman, O., and Nolan, C.M. (2003). IGF-I receptor mediates differentiation of primary cultures of mouse skeletal myoblasts. Mol. Cell. Endocrinol. 200, 19-29 https://doi.org/10.1016/S0303-7207(02)00420-3
- Jones, J.I., and Clemmons, D.R. (1995). Insulin-like growth factors and their binding proteins: biological action. Endocr. Rev. 16, 3-34
- Lee, D.K. (2002). Androgen receptor enhances myogenin expression and accelerates differentiation. Biochem. Biophys. Res. Commun. 294, 408-413 https://doi.org/10.1016/S0006-291X(02)00504-1
- Lee, W.J., McClung, J., Hand, G.A., and Carson, J.A. (2003a). Overload-induced androgen receptor expression in the aged hindlimb receiving nandrolone decanoate. J. Appl. Physiol. 94, 1153-1161 https://doi.org/10.1152/japplphysiol.00822.2002
- Lee, W.J., Thompson, R.W., McClung, J.M., and Carson, J.A. (2003b). Regulation of androgen receptor expression at the onset of functional overload in rat plantaris muscle. Am J. Physiol. Regul. Integr. Comp. Physiol. 285, R1076-R1085 https://doi.org/10.1152/ajpregu.00202.2003
- Lin, H.K., Yeh, S., Kang, H.Y., and Chang, C. (2001). Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc. Natl. Acad. Sci. USA 98, 7200-7205 https://doi.org/10.1073/pnas.121173298
- Lin, H.K., Hu, Y.C., Yang, L., Altuwaijri, S., Chen, Y.T., Kang, H.Y., and Chang, C. (2003). Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers. J. Biol. Chem. 278, 50902-50907 https://doi.org/10.1074/jbc.M300676200
- Lu, S., Liu, M., Epner, D.E., Tsai, S.Y., and Tsai, M.J. (1999). Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. Mol. Endocrinol. 13, 376-384 https://doi.org/10.1210/me.13.3.376
- MacLean, H.E., Chiu, W.S., Notini, A.J., Axell, A.M., Davey, R.A., McManus, J.F., Ma, C., Plant, D.R., Lynch, G.S., and Zajac, J.D. (2008). Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice. FASEB J. 22, 2676-2689 https://doi.org/10.1096/fj.08-105726
- McLellan, A.S., Kealey, T., and Langlands, K. (2006). An E box in the exon 1 promoter regulates insulin-like growth factor-I expression in differentiating muscle cells. Am. J. Physiol. 291, C300-C307
- Musaro, A., McCullagh, K.J., Naya, F.J., Olson, E.N., and Rosenthal, N. (1999). IGF-I induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400, 581-585 https://doi.org/10.1038/23060
- Nazareth, L.V., and Weigel, N.L. (1996). Activation of the human androgen receptor through a protein kinase A signaling pathway. J. Biol. Chem. 271, 19900-19907 https://doi.org/10.1074/jbc.271.33.19900
- Orio, F., Terouanne, B., Georget, V., Lumbroso, S., Avances, C., Siatka, C., and Sultan, C. (2002). Potential action of IGF-I and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines. Mol. Cell. Endocrinol. 198, 105-114 https://doi.org/10.1016/S0303-7207(02)00374-X
- Reinikainen, P., Palvimo, J.J., and Janne, O.A. (1996). Effects of mitogens on androgen receptor-mediated transactivation. Endocrinology 137, 4351-4357 https://doi.org/10.1210/en.137.10.4351
- Rommel, C., Bodine, S.C., Clarke, B.A., Rossman, R., Nunez, L., Stitt, T.N., and Glass, D.J. (2001). Mediation of IGF-I-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/kt/GSK3 pathways. Nat. Cell. Biol. 3, 1009-1013 https://doi.org/10.1038/ncb1101-1009
- Roy, A.K., Tyagi, R.K., Song, C.S, Lavrovsky, Y., Ahn, S.C., Oh, T.S., and Chatterjee, B. (2001). Androgen receptor: structural domains and functional dynamics after ligand-receptor interaction. Ann. N.Y. Acad. Sci. 949, 44-57 https://doi.org/10.1111/j.1749-6632.2001.tb04001.x
- Sadar, M.D. (1999). Androgen-independent induction of prostatespecific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways. J. Biol. Chem. 274, 7777-7783 https://doi.org/10.1074/jbc.274.12.7777
- Seaton, A., Scullin, P., Maxwell, P.J., Wilson, C., Pettigrew, J., Gallagher, R., O'Sullivan, J.M., Johnston, P.G., and Waugh, D.J. (2008). Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation. Carcinogenesis 29, 1148-1156 https://doi.org/10.1093/carcin/bgn109
- Taneja, S.S., Ha, S., Swenson, N.K., Huang, H.Y., Lee, P., Melamed, J., Shapiro, E., Garabedian, M.J., and Logan, S.K. (2005). Cell-specific regulation of androgen receptor phosphorylation in vivo. J. Biol. Chem. 280, 40916-40924 https://doi.org/10.1074/jbc.M508442200
- Tyagi, R.K., Lavrovsky, Y., Ahn, S.C., Song, S.C., Chatterjee, B., and Roy, A.K. (2000). Dynamics of intercellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol. Endocrinol. 14, 1162-1174 https://doi.org/10.1210/me.14.8.1162
- Urban, R.J., Boldenburg, Y.H., Gilkison, C., Foxworth, J., Coggan, A.R., Wolfe, R.R., and Ferrando, A. (1995). Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J. Physiol. 269, E820-E826
- Wade, N. (1972). Anabolic steroids: doctors denounce them, but athletes aren't listening. Science 176, 1399-1403 https://doi.org/10.1126/science.176.4042.1399
- Wannenes, F., Caprio, M., Gatta, L., Fabbri, A., Bonini, S., and Moretti, C. (2008). Androgen receptor expression during C2C12 skeletal muscle cell line differentiation. Mol. Cell. Endocrinol. 292, 11-19 https://doi.org/10.1016/j.mce.2008.05.018
- Wen, Y., Hu, M.C., Makino, K., Spohn, B., Bartholomeusz, G., Yan, D.H., and Hung, M.C. (2000). HER-2/neu promotes androgenindependent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res. 60, 6841-6845
- Wu, J.D., Haugk, K., Woodke, L., Nelson, P., Coleman, I., and Plymate, S.R. (2006). Interaction of IGF-signaling and the androgen receptor in prostate cancer progression. J. Cell. Biochem. 99, 392-401 https://doi.org/10.1002/jcb.20929
- Xu, L., Glass, C.K., and Rosenfeld, M.G. (2006). Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9, 140-147 https://doi.org/10.1016/S0959-437X(99)80021-5
Cited by
- Transcriptional alteration of p53 related processes as a key factor for skeletal muscle characteristics in Sus scrofa vol.28, pp.6, 2009, https://doi.org/10.1007/s10059-009-0159-z
- Ligand-independent activation of the androgen receptor by insulin-like growth factor-i and the role of the MAPK pathway in skeletal muscle cells vol.28, pp.6, 2009, https://doi.org/10.1007/s10059-009-0167-z
- C2C12 세포에서 insulin-like growth factor-I이 p38 MAPK, ERK1/2 신호전달 경로를 통해 엔드로젠 수용체 coactivator 발현에 미치는 영향 vol.21, pp.2, 2011, https://doi.org/10.5352/jls.2011.21.2.242
- Regulation of the androgen receptor by post-translational modifications vol.215, pp.2, 2009, https://doi.org/10.1530/joe-12-0238
- Effect of insulin-like growth factor-1 and hyaluronic acid in experimentally produced osteochondral defects in rats vol.50, pp.4, 2016, https://doi.org/10.4103/0019-5413.185607
- AR Signaling and the PI3K Pathway in Prostate Cancer vol.9, pp.4, 2017, https://doi.org/10.3390/cancers9040034
- Androgen interacts with exercise through the mTOR pathway to induce skeletal muscle hypertrophy vol.34, pp.4, 2017, https://doi.org/10.5114/biolsport.2017.69818
- Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications vol.20, pp.16, 2009, https://doi.org/10.3390/ijms20163881
- The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases? vol.11, pp.None, 2009, https://doi.org/10.3389/fimmu.2020.01567
- High-Load Resistance Exercise Augments Androgen Receptor–DNA Binding and Wnt/β-Catenin Signaling without Increases in Serum/Muscle Androgens or Androgen Receptor Content vol.12, pp.12, 2020, https://doi.org/10.3390/nu12123829